The New York Times @nytimes
A new study by Moderna suggests that its updated Covid booster strengthens a key component of the immune system’s defense against the Omicron subvariant that currently accounts for nearly one in three infections in the U.S. https://t.co/CxE8eLiOa1 — PolitiTweet.org